Adamas Pharmaceuticals Inc: 25-NSE filed Nov 24, 2021

Form type

25-NSE

Filing date

Nov 24, 2021

Accession number

0001354457-21-001375

Filer

Adamas Pharmaceuticals Inc (CIK 1328143)